Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Hemangiosarcoma

Below is an extended Hemangiosarcoma patents listing. Click here to return to the Hemangiosarcoma main in depth entry.

Patents :

US Patent No.Title
7271156 Immunostimulatory nucleic acids
7358335 ARF-BP1 as mediator of p53-dependent and independent tumor suppression and uses thereof
7365054 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
7371381 Anti-galanin antibodies and uses thereof
7371727 Methods and compositions for the treatment of gastrointestinal disorders
7378249 Treatment of cancer using TLR3 agonists
7407675 Anti-neoplastic compositions comprising extracts of black cohosh
7413864 Treating cancer using a telomerase vaccine
7425538 HAUSP-p53 interaction and uses thereof
7425619 Fc.gamma.RIIB specific antibodies and methods of use thereof
7425620 Fc.gamma.RIIB-specific antibodies and methods of use thereof
7355079 Thyronamine derivatives and analogs and methods of use thereof
7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same
7354584 Recombinant IL-9 antibodies
7291469 Mutant met and uses therefor
7304036 Methods and compositions for the treatment of gastrointestinal disorders
7307065 2'-Fluoronucleosides
7312241 Diphenylethylene compounds and uses thereof
7321065 Thyronamine derivatives and analogs and methods of use thereof
7332281 Therapeutic targets in cancer
7332288 Methods and reagents for the rapid and efficient isolation of circulating cancer cells
7339079 Thyronamine derivatives and analogs and methods of use thereof
7351729 JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers
7351739 Bioactive compounds and methods of uses thereof
7427605 Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7429595 Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
7521542 Humanized Fc.gamma.RIIB-specific antibodies and methods of use thereof
7534772 Methods for enhancing antibody-induced cell lysis and treating cancer
7538095 Genetic inhibition by double-stranded RNA
7560437 Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
7560438 Genetic inhibition by double-stranded RNA
7569553 Nucleic acid compositions for stimulating immune responses
7576066 Nucleic acid compositions for stimulating immune responses
7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase
7592422 Modified plasminogen activator inhibitor type-1 and methods based thereon
7604799 EphA4 Antibodies
7521446 Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith
7521053 Angiopoietin-2 specific binding agents
7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
7442778 Modified Fc molecules
7449555 Antibodies of angiogenesis inhibiting domains CD148
7468446 Substituted heterocyclic compounds and uses thereof
7470723 Diphenylethylene compounds and uses thereof
7473528 Method for the detection of Chagas disease related gene transcripts in blood
7479483 Tumor-targeted drug delivery systems and uses thereof
7494979 Method for treating congestive heart failure and other disorders
7498134 HAUSP-Mdm2 interaction and uses thereof
7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
7517949 Livin-derived peptides, compositions and uses thereof
7605138 Nucleic acid compositions for stimulating immune responses

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.